These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33534991)

  • 1. Updates in clinical data for FDA-approved disease-modifying therapies for spinal muscular atrophy.
    Bisaccia E
    Am J Manag Care; 2021 Feb; 27(1 Suppl):S3-S12. PubMed ID: 33534991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies.
    Angilletta I; Ferrante R; Giansante R; Lombardi L; Babore A; Dell'Elice A; Alessandrelli E; Notarangelo S; Ranaudo M; Palmarini C; De Laurenzi V; Stuppia L; Rossi C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective.
    Balaji L; Farrar MA; D'Silva AM; Kariyawasam DS
    Expert Rev Neurother; 2023; 23(7):571-586. PubMed ID: 37227306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expert consensus on newborn screening for spinal muscular atrophy (2023 edition)].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2075-2081. PubMed ID: 37455125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding caregiver experiences with disease-modifying therapies for spinal muscular atrophy: a qualitative study.
    Xiao L; Kang S; Djordjevic D; Gonorazky H; Chiang J; Ambreen M; Nigro E; Law E; Weinstock L; McCradden M; Amin R
    Arch Dis Child; 2023 Nov; 108(11):929-934. PubMed ID: 37419673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal muscular atrophy: an update for managed care pharmacists.
    Pannier AD
    Am J Manag Care; 2021 Feb; 27(1 Suppl):S13-S18. PubMed ID: 33534992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mixed method study on the impact of living with spinal muscular atrophy in Malaysia from patients' and caregivers' perspectives.
    Ch'ng GS; Koh K; Ahmad-Annuar A; Taib F; Koh CL; Lim ESC
    Orphanet J Rare Dis; 2022 May; 17(1):200. PubMed ID: 35578241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.
    Simon CM; Blanco-Redondo B; Buettner JM; Pagiazitis JG; Fletcher EV; Sime Longang JK; Mentis GZ
    J Neurosci; 2021 Jan; 41(2):376-389. PubMed ID: 33219005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and clinical management of spinal muscular atrophy.
    Han JJ; McDonald CM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):661-80, xii. PubMed ID: 18625423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nusinersen for the treatment of spinal muscular atrophy.
    Chiriboga CA
    Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.
    Sheikh O; Yokota T
    BioDrugs; 2021 Jul; 35(4):389-399. PubMed ID: 34097287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?
    Chen TH
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.
    Rossor AM; Oates EC; Salter HK; Liu Y; Murphy SM; Schule R; Gonzalez MA; Scoto M; Phadke R; Sewry CA; Houlden H; Jordanova A; Tournev I; Chamova T; Litvinenko I; Zuchner S; Herrmann DN; Blake J; Sowden JE; Acsadi G; Rodriguez ML; Menezes MP; Clarke NF; Auer Grumbach M; Bullock SL; Muntoni F; Reilly MM; North KN
    Brain; 2015 Feb; 138(Pt 2):293-310. PubMed ID: 25497877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy.
    Mousa MA; Aria DJ; Schaefer CM; Kaye RD; Abruzzo TA; Bernes SM; Willard SD; Riemann MC; Towbin RB
    Pediatr Radiol; 2018 Nov; 48(12):1797-1805. PubMed ID: 30022258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of hydrocephalus among patients with and without spinal muscular atrophy (SMA): Results from a US electronic health records study.
    Viscidi E; Wang N; Juneja M; Bhan I; Prada C; James D; Lallier S; Makepeace C; Laird K; Eaton S; Dilley A; Hall S
    Orphanet J Rare Dis; 2021 May; 16(1):207. PubMed ID: 33962637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.
    Zhou H; Meng J; Malerba A; Catapano F; Sintusek P; Jarmin S; Feng L; Lu-Nguyen N; Sun L; Mariot V; Dumonceaux J; Morgan JE; Gissen P; Dickson G; Muntoni F
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):768-782. PubMed ID: 32031328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal muscular atrophy: epidemiology and health burden in children - a Polish national healthcare database perspective before introduction of SMA-specific treatment.
    Kostera-Pruszczyk A; Napiórkowski Ł; Szymańska K; Jędrzejczak J; Roszkowski M; Słowiński J; Frączek A; Ryglewicz D; Więckowska B
    Neurol Neurochir Pol; 2021; 55(5):479-484. PubMed ID: 34664710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.